A team led by scientists from the University of Hong Kong has developed a new antibody drug that will not only protect people from contracting HIV but also serve as a long-acting treatment for the virus, unlike current medication that must be taken daily.
But there will need to be a further battery of tests before the drug, named “BiIA-SG”, can be part of the global battle against the virus, which causes Aids.
Hong Kong government cuts cash for HIV prevention, just as infections set...
↧